Emily Endres, BSPS, vice president of pharmacy at Innovaccer discuss the evolution of healthcare and provides insights into the industry’s next phase.
At the Total Pharmacy Solutions Summit Summer 2024, held July 13, Emily Endres, BSPS, vice president of pharmacy at Innovaccer, hosted a session titled “Strategies for Pharmacy Success: Navigating the Evolving Healthcare Landscape and Unlocking Alternate Revenue Streams.” In the presentation, Endres discussed the evolution of healthcare, as well as knowledge and skills that pharmacy professionals need to adapt to the changing environment.
“You can’t understand where you’re going if you don’t know where you have been,” Endres said during the session. “And what history tells us is that change in this industry is continuous, it’s expected, and it’s necessary. On the other side of that change will come some growth. What I think is really impactful about the history of our profession and this industry, is that if you think about it, in all of those eras, quality and care have been at the foundation of all of those changes.”
As the pharmacy industry continues to rapidly evolve, there will inevitably be many challenges that must be overcome. Among the difficulties today, Endres named reimbursement pressures, a lack of standardization, fragmented data, and trying to deliver the best quality of care while simultaneously increasing the volume of care that pharmacists provide. However, Endres said that by being bold, understanding goals, influencing patients, learning from history, and doing what works, pharmacists can excel in their career and overcome any obstacles that may come up in the future.
“The role of pharmacist and pharmacy is as important as ever,” Endres said. “We have this opportunity to change the course of the industry, create our own history, practice at the top of our license, and really continue the great work of community healthcare.”
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
2 Commerce Drive
Cranbury, NJ 08512